India
· Delayed Price · Currency is INR Neuland Laboratories Statistics
Total Valuation
NSE:NEULANDLAB has a market cap or net worth of INR 154.95 billion. The enterprise value is 154.14 billion.
| Market Cap | 154.95B |
| Enterprise Value | 154.14B |
Important Dates
The next estimated earnings date is Friday, May 9, 2025.
| Earnings Date | May 9, 2025 |
| Ex-Dividend Date | Jul 12, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 7.18M |
Valuation Ratios
The trailing PE ratio is 51.67.
| PE Ratio | 51.67 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 13.91 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 51.40 |
| EV / Sales | 10.05 |
| EV / EBITDA | 40.76 |
| EV / EBIT | 49.02 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 0.29 |
| Debt / FCF | n/a |
| Interest Coverage | 47.38 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 14.35% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 9.33M |
| Profits Per Employee | 1.83M |
| Employee Count | 1,643 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +87.90% in the last 52 weeks. The beta is 1.03, so NSE:NEULANDLAB's price volatility has been similar to the market average.
| Beta (5Y) | 1.03 |
| 52-Week Price Change | +87.90% |
| 50-Day Moving Average | 12,462.52 |
| 200-Day Moving Average | 12,365.80 |
| Relative Strength Index (RSI) | 53.02 |
| Average Volume (20 Days) | 52,783 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:NEULANDLAB had revenue of INR 15.33 billion and earned 3.00 billion in profits. Earnings per share was 233.72.
| Revenue | 15.33B |
| Gross Profit | 7.75B |
| Operating Income | 3.14B |
| Pretax Income | 3.99B |
| Net Income | 3.00B |
| EBITDA | 3.75B |
| EBIT | 3.14B |
| Earnings Per Share (EPS) | 233.72 |
Balance Sheet
The company has 1.90 billion in cash and 1.09 billion in debt, giving a net cash position of 808.72 million.
| Cash & Cash Equivalents | 1.90B |
| Total Debt | 1.09B |
| Net Cash | 808.72M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 13.95B |
| Book Value Per Share | 1,087.53 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 50.54%, with operating and profit margins of 20.51% and 19.55%.
| Gross Margin | 50.54% |
| Operating Margin | 20.51% |
| Pretax Margin | 26.03% |
| Profit Margin | 19.55% |
| EBITDA Margin | 24.45% |
| EBIT Margin | 20.51% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 14.00, which amounts to a dividend yield of 0.12%.
| Dividend Per Share | 14.00 |
| Dividend Yield | 0.12% |
| Dividend Growth (YoY) | 40.00% |
| Years of Dividend Growth | 3 |
| Payout Ratio | n/a |
| Buyback Yield | -0.01% |
| Shareholder Yield | 0.11% |
| Earnings Yield | 1.94% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |